PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for September 30, 2004 Subscribe to this News Feed    
 

Altus Pharmaceutical announces new generic product.

For pharmaceutical wholesalers and group purchasing organizations. Altus Pharmaceutical announces its generic product offering, Naproxen Sodium 550, 500's.

North Kingstown, RI (PRWEB) September 30, 2004 -- Altus Pharmaceutical, a wholly owned Division of Quality Pharmaceutical Services Inc. (QPS) announces availability of its initial generic product offering, Naproxen Sodium 550, 500's, NDC 68722-9908-05.

Altus is providing Private labeled Products, manufactured in the U.S. by FDA approved nationally recognized manufacturers.

Altus's value in the marketplace is hallmarked by price, service and post service capabilities. Altu's pricing is ultra competitive; its service is demonstrated through its shipping capability, i.e., orders received by noon ship the same day; orders received after twelve noon, ship the following day. Post Service includes computer parabolas anticipating customers future requrements and establishing inventory levels to service those needs.

Altus is actively developing additional product and invites inquires from wholesalers and/or buying organization. To inquire about existing or future product, please direct all inquires to Robert J. Budnick, 954 792-2400.
###

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Robert Budnick
ALTUS PHARMACEUTICAL
954 792-2400
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.